TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.
about
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
TIMP-1 and responsiveness to g ...... east cancer cooperative group.
@ast
TIMP-1 and responsiveness to g ...... east cancer cooperative group.
@en
type
label
TIMP-1 and responsiveness to g ...... east cancer cooperative group.
@ast
TIMP-1 and responsiveness to g ...... east cancer cooperative group.
@en
prefLabel
TIMP-1 and responsiveness to g ...... east cancer cooperative group.
@ast
TIMP-1 and responsiveness to g ...... east cancer cooperative group.
@en
P2093
P2860
P356
P1433
P1476
TIMP-1 and responsiveness to g ...... east cancer cooperative group.
@en
P2093
Annette Bartels
Charlotte Levin Tykjær Jørgensen
Christina Bjerre
Dorte L Nielsen
Eva Balslev
Karsten D Bjerre
Nils Brünner
P2860
P2888
P356
10.1186/1471-2407-14-360
P407
P577
2014-05-22T00:00:00Z
P5875
P6179
1001268560